Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Chem Biol Drug Des. 2009 Sep;74(3):246–257. doi: 10.1111/j.1747-0285.2009.00855.x

Figure 2.

Figure 2

Template of the small molecule designed based on the structure shown in Figure 2. An Arg or Lys amino acid residue or surrogates of these amino acids can be used at the N-terminal and a hydrophobic residue can be used at the C-terminal. These can be connected by a conformationally constrained spacer group. Peptides/peptidomimetics or small organic molecules designed based on this template are proposed to fit in the cavity of HER2 domain IV.